# FDA Inspection 1286502 - Biocon Generics Inc. - October 10, 2025

Source: https://www.keypedia.com/records/fda_inspections/biocon-generics-inc/bff19b88-665e-45f3-8c69-560621c8beba
Source feed: FDA_Inspections

> FDA Inspection 1286502 for Biocon Generics Inc. on October 10, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1286502
- Company Name: Biocon Generics Inc.
- Inspection Date: 2025-10-10
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Office Name: New Jersey District Office

## Related Documents

- [FDA Inspection 1162361 - 2022-02-02](https://www.keypedia.com/records/fda_inspections/biocon-generics-inc/49a9311f-111e-4b41-8361-590b86e8c1a2)

Company: https://www.keypedia.com/companies/biocon-generics-inc/6a3ff7cc-6109-49f1-a410-0ff09273673f

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248